Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1

Interventions

apixaban 5 Rivaroxaban 5 Dalteparin 4 Enoxaparin 3 edoxaban 2 abelacimab 2 Tinzaparin 2 MAA868 2 Heparin, Low-Molecular-Weight 2 Dabigatran 2 isoquercitrin 1 calcium heparin 1 betrixaban 1 bemiparin 1 Warfarin 1 Heparin 1 Gemcitabine 1 Fondaparinux 1 AVE 5026 1 ALT-836 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Venous Thromboembolism × betrixaban × Clear all

NCT01583218 2023-08-07

APEX

Alexion Pharmaceuticals, Inc.

Phase 3 Completed

7,513 enrolled 18 charts 1 FDA

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡